Skip to main content

Breast Cancer Research and Treatment

Ausgabe 3/2022

Inhalt (22 Artikel)

Open Access Preclinical study

Clever-1 positive macrophages in breast cancer

Minna Mutka, Reetta Virtakoivu, Kristiina Joensuu, Maija Hollmén, Päivi Heikkilä

Preclinical study

The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary

Jan J. Jobsen, Henk Struikmans, Ester Siemerink, Job van der Palen, Harald J. Heijmans

Open Access Preclinical study

BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance

Midas M. Kuilman, Architha Ellappalayam, Andrei Barcaru, Josien C. Haan, Rajith Bhaskaran, Diederik Wehkamp, Andrea R. Menicucci, William M. Audeh, Lorenza Mittempergher, Annuska M. Glas

Open Access Clinical trial

An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer

Elgene Lim, Frances Boyle, Meena Okera, Sherene Loi, Sema Sezgin Goksu, Gertjan van Hal, Sonya C. Chapman, Jonathon Colby Gable, Yanyun Chen, Gregory L. Price, Anwar M. Hossain, M. Corona Gainford, Meritxell Bellet Ezquerra

Clinical trial

Surgical and obstetric outcomes of breast cancer surgery during pregnancy: a nationwide database study in Japan

Takaaki Konishi, Michimasa Fujiogi, Daisuke Shigemi, Kotoe Nishioka, Hiroki Matsui, Kiyohide Fushimi, Masahiko Tanabe, Yasuyuki Seto, Hideo Yasunaga

Clinical trial

Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study

Xinguang Wang, Zhaoqing Fan, Xing Wang, Yingjian He, Yiqiang Liu, Xiang Wang, Bailin Zhang, Zefei Jiang, Tao Wang, Zhigang Yu, Fei Wang, Yinhua Liu, Yanping Li, Jianguo Zhang, Bin Luo, Hongchuan Jiang, Tianfeng Wang, Yuntao Xie, Jinfeng Li, Tao Ouyang

COVID-19 Clinical trial

Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study

Mitsuo Terada, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Akiko Kato, Natsumi Yamanaka, Hiroshi Sugiura, Keiko Mita, Asaka Wada, Eriko Takahashi, Kanako Saito, Ryo Yoshioka, Tatsuya Toyama

Open Access Clinical trial

The influence of body mass index on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in women with early-stage breast cancer

Lishi Lin, Marcel Soesan, Dorieke E. M. van Balen, Jos H. Beijnen, Alwin D. R. Huitema

Clinical trial

Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital

Niamh Cunningham, Scott Shepherd, Kabir Mohammed, Karla A. Lee, Mark Allen, Stephen Johnston, Emma Kipps, Sophie McGrath, Jillian Noble, Marina Parton, Alistair Ring, Nicholas C. Turner, Alicia F. C. Okines

Clinical trial

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study

Elaine M. Walsh, Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S. Ross, Pedram Razavi, Shanu Modi, Neil M. Iyengar, Rachel Sanford, Tiffany Troso-Sandoval, Mila Gorsky, Jacqueline Bromberg, Pamela Drullinsky, Diana Lake, Serena Wong, Patricia Ann DeFusco, Nicholas Lamparella, Ranja Gupta, Tasmila Tabassum, Leigh Ann Boyle, Artavazd Arumov, Tiffany A. Traina

Epidemiology

Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women's Health History Study

Ugonna Ihenacho, Ann S. Hamilton, Wendy J. Mack, Anna H. Wu, Jennifer B. Unger, Dorothy R. Pathak, Kelly A. Hirko, Richard T. Houang, Michael F. Press, Kendra L. Schwartz, Lydia R. Marcus, Ellen M. Velie

Open Access Epidemiology

Correlation of tumour subtype with long-term outcome in small breast carcinomas: a Swedish population-based retrospective cohort study

Gunilla Rask, Anoosheh Nazemroaya, Malin Jansson, Charlotta Wadsten, Greger Nilsson, Carl Blomqvist, Lars Holmberg, Fredrik Wärnberg, Malin Sund

Open Access Epidemiology

Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study

Kristina Engvall, Henrik Gréen, Mats Fredrikson, Magnus Lagerlund, Freddi Lewin, Elisabeth Åvall-Lundqvist

Open Access Epidemiology

Cardiotoxicity among socioeconomically marginalized breast cancer patients

Yan Lu, Aaron W. Gehr, Ifedioranma Anikpo, Rachel J. Meadows, Kevin J. Craten, Kalyani Narra, Anuradha Lingam, Sandeep Kamath, Bhavna Tanna, Bassam Ghabach, Rohit P. Ojha

Epidemiology

Barriers to breast reconstruction for socioeconomically disadvantaged women

Trista J. Stankowski, Jessica R. Schumacher, Bret M. Hanlon, Jennifer L. Tucholka, Manasa Venkatesh, Dou-Yan Yang, Samuel O. Poore, Heather B. Neuman

Epidemiology

Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes

Soumya G. Chikermane, Manvi Sharma, Susan M. Abughosh, Rajender R. Aparasu, Meghana V. Trivedi, Michael L. Johnson

Open Access Epidemiology

Treatment of HR+/HER2− breast cancer in urban mainland China: results from the CancerMPact Survey 2019

Bhavna Murali, Laura Durbin, Sapna Vijaykumar, Linda Yang, Song Li, Linda Zhao, Stephanie Hawthorne, Gena Kanas, Christine Davis, Otávio Clark

Brief Communication

Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine

Anastasiia Samusieva, Svitlana Serga, Sergiy Klymenko, Lyudmila Rybchenko, Bohdana Klimuk, Liubov Zakhartseva, Natalia Gorovenko, Olga Lobanova, Zoia Rossokha, Liliia Fishchuk, Nataliia Levkovich, Nataliia Medvedieva, Olena Popova, Valeriy Cheshuk, Mariia Inomistova, Natalia Khranovska, Oksana Skachkova, Yurii Michailovich, Olga Ponomarova, Iryna Kozeretska

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.